Novartis Investigative Site

Basel, CH 4002

0 studies enrolling now · 3 studies all time

What they study most

Alzheimers Disease, Sarcopenia

Studies at this site

• A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease — Stopped early
• A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease — Stopped early
• Dose Range Finding Study of Bimagrumab in Sarcopenia — Completed